Literature DB >> 18618715

Integrated genomic and transcriptional profiling identifies chromosomal loci with altered gene expression in cervical cancer.

Saskia M Wilting1, Jillian de Wilde, Chris J L M Meijer, Johannes Berkhof, Yajun Yi, Wessel N van Wieringen, Boudewijn J M Braakhuis, Gerrit A Meijer, Bauke Ylstra, Peter J F Snijders, Renske D M Steenbergen.   

Abstract

For a better understanding of the consequences of recurrent chromosomal alterations in cervical carcinomas, we integrated genome-wide chromosomal and transcriptional profiles of 10 squamous cell carcinomas (SCCs), 5 adenocarcinomas (AdCAs) and 6 normal controls. Previous genomic profiling showed that gains at chromosome arms 1q, 3q, and 20q as well as losses at 8q, 10q, 11q, and 13q were common in cervical carcinomas. Altered regions spanned multiple megabases, and the extent to which expression of genes located there is affected remains unclear. Expression analysis of these previously chromosomally profiled carcinomas yielded 83 genes with significantly differential expression between carcinomas and normal epithelium. Application of differential gene locus mapping (DIGMAP) analysis and the array CGH expression integration tool (ACE-it) identified hotspots within large chromosomal alterations in which gene expression was altered as well. Chromosomal gains of the long arms of chromosome 1, 3, and 20 resulted in increased expression of genes located at 1q32.1-32.2, 3q13.32-23, 3q26.32-27.3, and 20q11.21-13.33, whereas a chromosomal loss of 11q22.3-25 was related to decreased expression of genes located in this region. Overexpression of DTX3L, PIK3R4, ATP2C1, and SLC25A36, all located at 3q21.1-23 and identified by DIGMAP, ACE-it or both, was confirmed in an independent validation sample set consisting of 12 SCCs and 13 normal ectocervical samples. In conclusion, integrated chromosomal and transcriptional profiling identified chromosomal hotspots at 1q, 3q, 11q, and 20q with altered gene expression within large commonly altered chromosomal regions in cervical cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18618715      PMCID: PMC2733213          DOI: 10.1002/gcc.20590

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  57 in total

1.  Identification of chromosomal alterations important in the development of cervical intraepithelial neoplasia and invasive carcinoma using alignment of DNA microarray data.

Authors:  Margaret A Fitzpatrick; Margo C Funk; David Gius; Phyllis C Huettner; Zhengyan Zhang; Miri Bidder; Duanduan Ma; Matthew A Powell; Janet S Rader
Journal:  Gynecol Oncol       Date:  2006-05-02       Impact factor: 5.482

2.  Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: identification of candidate amplified and overexpressed genes.

Authors:  Gopeshwar Narayan; Veronique Bourdon; Seeta Chaganti; Hugo Arias-Pulido; Subhadra V Nandula; Pulivarthi H Rao; Lutz Gissmann; Matthias Dürst; Achim Schneider; Bhavana Pothuri; Mahesh Mansukhani; Katia Basso; R S K Chaganti; Vundavalli V Murty
Journal:  Genes Chromosomes Cancer       Date:  2007-04       Impact factor: 5.006

Review 3.  A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications.

Authors:  Boudewijn J M Braakhuis; Maarten P Tabor; J Alain Kummer; C René Leemans; Ruud H Brakenhoff
Journal:  Cancer Res       Date:  2003-04-15       Impact factor: 12.701

4.  Identification of cervical cancer markers by cDNA and tissue microarrays.

Authors:  Yan Chen; Christine Miller; Rebecca Mosher; Xumei Zhao; Jim Deeds; Mike Morrissey; Barb Bryant; David Yang; Ron Meyer; Frank Cronin; Bobbie S Gostout; Karen Smith-McCune; Robert Schlegel
Journal:  Cancer Res       Date:  2003-04-15       Impact factor: 12.701

5.  Comparison of gene expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.

Authors:  Stephen A Contag; Bobbie S Gostout; Amy C Clayton; Melanie H Dixon; Renee M McGovern; Eric S Calhoun
Journal:  Gynecol Oncol       Date:  2004-12       Impact factor: 5.482

6.  Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation.

Authors:  Claudio Talora; Dennis C Sgroi; Christopher P Crum; G Paolo Dotto
Journal:  Genes Dev       Date:  2002-09-01       Impact factor: 11.361

7.  Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia.

Authors:  Kerstin Heselmeyer-Haddad; Viktor Janz; Philip E Castle; Nadia Chaudhri; Nicole White; Kim Wilber; Larry E Morrison; Gert Auer; Frances H Burroughs; Mark E Sherman; Thomas Ried
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

8.  Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma.

Authors:  Robbert J C Slebos; Yajun Yi; Kim Ely; Jesse Carter; Amy Evjen; Xueqiong Zhang; Yu Shyr; Barbara M Murphy; Anthony J Cmelak; Brian B Burkey; James L Netterville; Shawn Levy; Wendell G Yarbrough; Christine H Chung
Journal:  Clin Cancer Res       Date:  2006-02-01       Impact factor: 12.531

9.  Overexpression of cathepsin F, matrix metalloproteinases 11 and 12 in cervical cancer.

Authors:  Guelaguetza Vazquez-Ortiz; Patricia Pina-Sanchez; Karla Vazquez; Alfonso Duenas; Lucia Taja; Patricia Mendoza; José A Garcia; Mauricio Salcedo
Journal:  BMC Cancer       Date:  2005-06-30       Impact factor: 4.430

10.  Microarray comparative genomic hybridization detection of chromosomal imbalances in uterine cervix carcinoma.

Authors:  Alfredo Hidalgo; Michael Baudis; Iver Petersen; Hugo Arreola; Patricia Piña; Guelaguetza Vázquez-Ortiz; Dulce Hernández; José González; Minerva Lazos; Ricardo López; Carlos Pérez; José García; Karla Vázquez; Brenda Alatorre; Mauricio Salcedo
Journal:  BMC Cancer       Date:  2005-07-09       Impact factor: 4.430

View more
  35 in total

Review 1.  Physiological and pathological roles of mitochondrial SLC25 carriers.

Authors:  Manuel Gutiérrez-Aguilar; Christopher P Baines
Journal:  Biochem J       Date:  2013-09-15       Impact factor: 3.857

2.  Frequent genetic abnormalities of the PI3K/AKT pathway in primary ovarian cancer predict patient outcome.

Authors:  Jia Huang; Lin Zhang; Joel Greshock; Theresa A Colligon; Yan Wang; Renee Ward; Dionyssios Katsaros; Heini Lassus; Ralf Butzow; Andrew K Godwin; Joseph R Testa; Katherine L Nathanson; Phyllis A Gimotty; George Coukos; Barbara L Weber; Yan Degenhardt
Journal:  Genes Chromosomes Cancer       Date:  2011-05-11       Impact factor: 5.006

3.  Molecular fixative enables expression microarray analysis of microdissected clinical cervical specimens.

Authors:  Gerald Li; Dirk van Niekerk; Dianne Miller; Thomas Ehlen; Cathie Garnis; Michele Follen; Martial Guillaud; Calum Macaulay
Journal:  Exp Mol Pathol       Date:  2014-01-08       Impact factor: 3.362

4.  Activation of the NOTCH pathway in head and neck cancer.

Authors:  Wenyue Sun; Daria A Gaykalova; Michael F Ochs; Elizabeth Mambo; Demetri Arnaoutakis; Yan Liu; Myriam Loyo; Nishant Agrawal; Jason Howard; Ryan Li; Sun Ahn; Elana Fertig; David Sidransky; Jeffery Houghton; Kalyan Buddavarapu; Tiffany Sanford; Ashish Choudhary; Will Darden; Alex Adai; Gary Latham; Justin Bishop; Rajni Sharma; William H Westra; Patrick Hennessey; Christine H Chung; Joseph A Califano
Journal:  Cancer Res       Date:  2013-12-18       Impact factor: 12.701

5.  The zinc finger protein ZNF268 is overexpressed in human cervical cancer and contributes to tumorigenesis via enhancing NF-κB signaling.

Authors:  Wei Wang; Mingxiong Guo; Li Hu; Jinyang Cai; Yan Zeng; Jun Luo; Zhiqiang Shu; Wenxin Li; Zan Huang
Journal:  J Biol Chem       Date:  2012-10-22       Impact factor: 5.157

6.  SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas.

Authors:  Thomas Hussenet; Soraya Dali; Julien Exinger; Ben Monga; Bernard Jost; Doulaye Dembelé; Nadine Martinet; Christelle Thibault; Joerg Huelsken; Elisabeth Brambilla; Stanislas du Manoir
Journal:  PLoS One       Date:  2010-01-29       Impact factor: 3.240

7.  The mRNA decay factor tristetraprolin (TTP) induces senescence in human papillomavirus-transformed cervical cancer cells by targeting E6-AP ubiquitin ligase.

Authors:  Sandhya Sanduja; Vimala Kaza; Dan A Dixon
Journal:  Aging (Albany NY)       Date:  2009-09-10       Impact factor: 5.682

8.  Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer.

Authors:  Saskia M Wilting; Robert A A van Boerdonk; Florianne E Henken; Chris J L M Meijer; Begona Diosdado; Gerrit A Meijer; Carlos le Sage; Reuven Agami; Peter J F Snijders; Renske D M Steenbergen
Journal:  Mol Cancer       Date:  2010-06-26       Impact factor: 27.401

Review 9.  Emerging roles of E2Fs in cancer: an exit from cell cycle control.

Authors:  Hui-Zi Chen; Shih-Yin Tsai; Gustavo Leone
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

10.  Gene dosage, expression, and ontology analysis identifies driver genes in the carcinogenesis and chemoradioresistance of cervical cancer.

Authors:  Malin Lando; Marit Holden; Linn C Bergersen; Debbie H Svendsrud; Trond Stokke; Kolbein Sundfør; Ingrid K Glad; Gunnar B Kristensen; Heidi Lyng
Journal:  PLoS Genet       Date:  2009-11-13       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.